missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human EGF Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Brand: R&D Systems™ 236-EG-200
158.96 EUR valid until 2024-12-16
Use promo code "21630" to get your promotional price.
This item is not returnable.
View return policy
Description
Measured in a cell proliferation assay using Balb/3T3 mouse embryonic fibroblast cells. Rubin, J.S. et al. (1991) Proc. Natl. Acad. Sci. USA 88:415. The ED50 for this effect is 20-100 pg/mL.Specifications
| P01133 | |
| Lyophilized from a 0.2 μm filtered solution in PBS. | |
| M.W. (Observed): 6 kDa, reducing conditions; M.W. (theoretical): 6 kDa | |
| 200 μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. | |
| EGF | |
| Recombinant | |
| >97%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining. |
| Bioactivity | |
| 1950 | |
| EGF | |
| E. coli-derived human EGF protein Asn971-Arg1023, with an N-terminal Met | |
| <0.10 EU / 1 μg of the protein by the LAL method. | |
| Unconjugated | |
| Reconstitute at 500 μg/mL in sterile PBS. | |
| EGF |